732-761-1740 Office hours: MondayFriday, 9 a.m
Key Findings: Positive Outcomes for Obese HS Patients The study, conducted between June 2020 and March 2023, involved 30 obese individuals with varying degrees of HS who received semaglutide weekly for an average duration of 8.2 months
Speak to a provider and get expert guidance tailored to your weight loss goals
How Semaglutide Compares to Traditional Options Historically, weight loss medications often focused on appetite suppression or fat absorption inhibition
Problem: I have Medicare or Medicaid, am I just automatically disqualified
This condition, called telogen effluvium, is triggered by the weight loss itself, not the specific medication